610 related articles for article (PubMed ID: 24963568)
1. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
3. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF; Kanyama C; Heyderman RS; Loyse A; Kouanfack C; Chanda D; Mfinanga S; Temfack E; Lakhi S; Lesikari S; Chan AK; Stone N; Kalata N; Karunaharan N; Gaskell K; Peirse M; Ellis J; Chawinga C; Lontsi S; Ndong JG; Bright P; Lupiya D; Chen T; Bradley J; Adams J; van der Horst C; van Oosterhout JJ; Sini V; Mapoure YN; Mwaba P; Bicanic T; Lalloo DG; Wang D; Hosseinipour MC; Lortholary O; Jaffar S; Harrison TS;
N Engl J Med; 2018 Mar; 378(11):1004-1017. PubMed ID: 29539274
[TBL] [Abstract][Full Text] [Related]
4. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
[TBL] [Abstract][Full Text] [Related]
5. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
[TBL] [Abstract][Full Text] [Related]
6. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
Bisson GP; Molefi M; Bellamy S; Thakur R; Steenhoff A; Tamuhla N; Rantleru T; Tsimako I; Gluckman S; Ravimohan S; Weissman D; Tebas P
Clin Infect Dis; 2013 Apr; 56(8):1165-73. PubMed ID: 23362285
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of AIDS-associated cryptomeningitis.
Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
[TBL] [Abstract][Full Text] [Related]
8. Combination antifungal therapy for cryptococcal meningitis.
Day JN; Chau TTH; Wolbers M; Mai PP; Dung NT; Mai NH; Phu NH; Nghia HD; Phong ND; Thai CQ; Thai LH; Chuong LV; Sinh DX; Duong VA; Hoang TN; Diep PT; Campbell JI; Sieu TPM; Baker SG; Chau NVV; Hien TT; Lalloo DG; Farrar JJ
N Engl J Med; 2013 Apr; 368(14):1291-1302. PubMed ID: 23550668
[TBL] [Abstract][Full Text] [Related]
9. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.
Rhein J; Huppler Hullsiek K; Tugume L; Nuwagira E; Mpoza E; Evans EE; Kiggundu R; Pastick KA; Ssebambulidde K; Akampurira A; Williams DA; Bangdiwala AS; Abassi M; Musubire AK; Nicol MR; Muzoora C; Meya DB; Boulware DR;
Lancet Infect Dis; 2019 Aug; 19(8):843-851. PubMed ID: 31345462
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
Rhein J; Morawski BM; Hullsiek KH; Nabeta HW; Kiggundu R; Tugume L; Musubire A; Akampurira A; Smith KD; Alhadab A; Williams DA; Abassi M; Bahr NC; Velamakanni SS; Fisher J; Nielsen K; Meya DB; Boulware DR;
Lancet Infect Dis; 2016 Jul; 16(7):809-818. PubMed ID: 26971081
[TBL] [Abstract][Full Text] [Related]
12. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
[TBL] [Abstract][Full Text] [Related]
13. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
[TBL] [Abstract][Full Text] [Related]
14. Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.
Kitonsa J; Nsubuga R; Mayanja Y; Kiwanuka J; Nikweri Y; Onyango M; Anywaine Z; Ggayi AB; Kibengo FM; Kaleebu P; Day J
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008823. PubMed ID: 33253210
[TBL] [Abstract][Full Text] [Related]
15. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
Bicanic T; Meintjes G; Wood R; Hayes M; Rebe K; Bekker LG; Harrison T
Clin Infect Dis; 2007 Jul; 45(1):76-80. PubMed ID: 17554704
[TBL] [Abstract][Full Text] [Related]
16. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
[TBL] [Abstract][Full Text] [Related]
17. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L
Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
20. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE;
N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]